Spectrum of cardiac involvement in neonatal lupus

Scandinavian Journal of Immunology

Volumn 72, Issue 3, 2010, Pages 189-197

  Hornberger, L K ^a,b   Al Rajaa, N ^a,b  

^a Division of Cardiology   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LA ANTIBODY; RO ANTIBODY;

ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; DISEASE ASSOCIATION; ENDOCARDIAL FIBROELASTOSIS; HEART ATRIUM ARRHYTHMIA; HEART DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HEART VENTRICLE ARRHYTHMIA; HUMAN; LUPUS ERYTHEMATOSUS; MYOCARDITIS; NEONATAL LUPUS; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VALVULAR HEART DISEASE; ARRHYTHMIAS, CARDIAC; CARDIOMYOPATHIES; COMPLICATION; HEART DISEASES; IMMUNOLOGY; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY;

ARRHYTHMIAS, CARDIAC; ATRIOVENTRICULAR BLOCK; CARDIOMYOPATHIES; HEART DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 77955298341     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2010.02437.x     Document Type: Review

References (55)

1. Cimaz RG, Spence D, Hornberger LK, Silverman ED. Defining the incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 2003 142 : 678 683.
2. Morquio L. Sur une maladie infantile et familiale characterise′e par des modifications permanentes du pouls des attaques syncopales et eptileptiformes et la mort subite. Arch Med Infant 1901 4 : 467 469.
3. Van den Heuvel GCJ. Die ziekte van Stokes-Adams en een geval van aangeboren hart block. Groningen, 1908.
4. Hull D, Binns BA, Joyce D. Congenital heart block and widespread fibrosis due to maternal lupus erythematosus. Arch Dis Child 1966 41 : 688 690.
5. Franco HL, Weston WL, Peebles C, Forstot SL, Phanuphak P. Autoantibodies directed against sicca syndrome antigens in the neonatal lupus syndrome. J Am Acad Dermatol 1981 4 : 67 72.
6. Weston WL, Harmon C, Peebles C et al. A serological marker for neonatal lupus. Br J Dermatol 1982 107 : 377 382.
7. Kephart DC, Hood AF, Provost TT. NLE:new serologic findings. J Invest Dermatol 1981 77 : 331 333.
8. Lockshin MD, Gibofsky A, Peebles C, Gigli I, Fotino M, Hurwitz S. NLE with heart block:family study of a patient with anti SS-A and SS-B antibodies. Arthritis Rheum 1983 26 : 210 213.
9. Scott JS, Maddison PJ, Taylor PV, Esscher E, Scott O, Skinner RP. Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med 1983 309 : 209 212.
10. Ho YS, Esscher E, Anderson RH, Michaelsson M. Anatomy of congenital complete heart block and relation to maternal ant-Ro antibodies. Am J Cardiol 1986 58 : 291 294.
11. Taylor PV, Taylor KF, Norman A, Griffiths S, Scott JS. Prevalence of maternal Ro (SS-A) and La (SS-B) autoantibodies in relation to congenital heart block. Br J Rheumatol 1988 27 : 128 132.
12. Brucato A, Cimaz R, Stramba-Badiale M. Neonatal Lupus. Clin Rev Allergy Immunol 2002 23 : 279 299.
13. Buyon JP, Waltuck J, Kleinman C, Copel J. In utero identification and therapy of congenital heart block (CHB). Lupus 1995 4 : 116 121.
14. Jaeggi ET, Hamilton RM, Silverman ED, Zamora SA, Hornberger LK. Outcome of children with Fetal Neonatal or Childhood Diagnosis of Isolated complete heart block. A single institution's experience. J Am Coll Cardiol 2002 39 : 130 137.
15. Brucato A, Cimaz R, Caporali R, Ramoni V, Buyon J. Pregnancy outcomes in patients with autoimmune disease and Anti-Ro/SSA antibodies. Clin Rev Allergy Immunol 2009 12016 : 8190 8196.
16. Litsey SE, Noonan JA, O'Connor WN, Cottrill CM, Mitchell B. Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med 1985 312 : 98 100.
17. Buyon JP, Clancy RM. Maternal and congenital heart block: Mediators, Markers, Therapeutic Approach. Semin Arthritis Rheum 2003 33 : 140 154.
18. Clancy RM, Alvarez D, Komissarova E, Barrat FJ, Swartz J, Buyon JP. Ro60-associated single- strand RNA links inflammation with fetal cardiac fibrosis via ligation of TLRs: a novel pathway to autoimmune-associated heart block. J Immunol 2010 184 : 2148 2155.
19. Motta M, Rodriguez-Perez C, Tincani A, Lojacono A, Nacinovich R, Chirico G. Neonates born from mothers with autoimmune disorders. Early Hum Dev 2009 85 : S67 70.
20. Boutjdir M, Chen L, Zhang Z-H et al. Arrhythmogenicity of IgG and anti-52-kD SSA/Ro Affinity-purified antibodies from mothers of children with congenital heart block. Circ Res 1997 80 : 354 362.
21. Wahren-Herlenius M, Sonesson S-E. Specificity and effector mechanisms of autoantibodies in congenital heart block. Curr Opin Immunol 2006 18 : 690 696.
22. Llanos C, Izmirly PM, Katholi M et al. Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors. Arthritis Rheum 2009 60 : 3091 3097.
23. Friedman DM, Llanos C, Izmirly PM et al. Evaluation of fetuses in a study on intravenous immunoglobulin as preventative therapy for congenital heart block:results of a multicenter, prospective, open-label clinical trial. Arthritis Rheum 2009 62 : 1138 1146.
24. Pisoni CN, Brucato A, Ruffatti A et al. Failure of intravenous immunoglobulin to prevent congenital heart blcok:findings of a multicenter, prospective observational study. Arthritis Rheum 2010 62 : 1147 1152.
25. Gordon P, Khamashta MA, Rosenthal E et al. Anti-52 kDa, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus. J Rheumatol 2004 31 : 2480 2487.
26. Jaeggi E, Laskin C, Hamilton R, Kingdom J, Silverman E. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus: a prospective study of 186 antibody-exposed fetuses and infants. J Am Coll Cardiol 2010 55 : 2778 2784.
27. Spence D, Hornberger L, Hamilton R, Silverman ED. Increased risk of complete congenital heart block in infants born to women with hypothyroidism and anti-Ro and/or anti-La antibodies. J Rheumatol 2006 33 : 167 170.
28. Sonesson S. Diagnosing fetal atrioventricular heart blocks. Scand J Immunol 2010 72 : 205 212.
29. Zhao H, Cuneo BF, Strasburger JF, Huhta JC, Gotteiner NL, Wakai RT. Electrophysiological Characteristics of Fetal Atrioventricular Block. J Am Coll Cardiol 2008 51 : 77 84.
30. Hornberger LK, Collins K. New insights into fetal AV Block using fetal Magnetocardiography (editorial comment). J Am Coll Cardiol 2008 51 : 85 6.
31. Nii M, Hamilton RM, Fenwick L, Kingdom JCP, Roman KS, Jaeggi ET. Assessment of fetal AV time intervals by tissue Doppler and pulsed Doppler echocardiography: normal values and correlation with fetal electrocardiography. Heart 2006 92 : 1831 1837.
32. Bergman G, Wahren-Herlenius M, Sonesson S-E. Diagnostic precision of Doppler flow echocardiography in fetuses at risk for atrioventricular block. Ultrasound Obstet Gynecol 2009 DOI:.
33. Friedman DM, Kim MY, Copel JA et al. Utility of Cardiac Monitoring in Fetuses at Risk for Congenital Heart Block The PR Interval and Dexamethasone Evaluation (PRIDE) Prospective Study. Circulation 2008 117 : 485 493.
34. Rein AJJT, Mevorach D, Perles Z et al. Early Diagnosis and Treatment of Atrioventricular Block in the Fetus Exposed to Maternal Anti-SSA/Ro-SSB/La Antibodies. Circulation 2009 119 : 1867 1872.
35. Gardiner HM, Belmar C, Pasquini L et al. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies. Heart 2007 93 : 1454 1460.
36. Hutter D, Silverman E, Jaeggi E. The benefits of transplacental treatment of isolated congenital complete heart block associated with maternal anti-Ro/SSA antibodies: a review. Scand J Immunol 2010 72 : 235 241.
37. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 2008 117 2820 2840.
38. Eronen M, Siren MK, Ekblad H, Tikanoja T, Julkunen H, Paavilainen T. Short- and long-term outcome of children with congenital complete heart block diagnosed in utero or as a newborn. Pediatrics 2000 106 : 86 91.
39. Nield LE, Silverman ED, Taylor GP et al. Maternal Anti-Ro and Anti-La Antibody-Associated Endocardial Fibroelastosis. Circulation 2002 105 : 843 848.
40. Nield LE, Silverman ED, Smallhorn JF et al. Endocardial fibroelastosis associated with maternal anti-Ro and anti-la antibodies in the absence of atrioventricular block. J Am Coll Cardiol 2002 40 : 796 802.
41. Moak JP, Barron KS, Hougen TJ et al. Congenital heart block: development of late-onset cardiomyopathy, a previously underappreciated sequela. J Am Coll Cardiol 2001 37 : 238 242.
42. Herreman G, Galezewski N. Maternal connective tissue disease and congenital heart block (letter). N Engl J Med 1985 312 : 1329.
43. Buyon JP, Swersky SH, Fox HE, Bierman FZ, Winchester RJ. Intrauterine therapy of presumptive fetal myocarditis with heart block occurring in a mother with systemic lupus erythematosus and predominance of La (SSB) antibodies. Arthritis Rheum 1987 30 : 44 9.
44. Angelini A, Moreolo GS, Ruffatti A, Milanesi O, Thiene G. Calcification of the AV node in a fetus affected by congenital complete heart block. Circulation 2002 105 : 1254 1255.
45. Saleeb S, Copel J, Friedman D, Buyon JP. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus. Arthritis Rheum 1999 42 : 2335 2345.
46. Trucco S, Jaeggi E, Cuneo B, Moon-Grady A, Silverman E, Hornberger LK. Intravenous Gamaglobulin and corticosteroids in the treatment of maternal autoimmune-mediated fetal cardiomyopathy. Pediatr Acad Soc (Abstract) 2008 (4489.8)
47. Gerosa M, Cimaz R, Stramba-Baiale M et al. Electocardiographic abnormalities in infants born from mothers with autoimmune disease -a multi-center prospective study. Rheumatology 2007 46 : 1285 1289.
48. Cimaz R, Stramba-Badiale M, Brucato A, Catelli L, Panzeri P, Meroni PL. QT interval prolongation in asymptomatic anti-SSA/Ro-positive infants without congenital heart block. Arthritis Rheum 2000 43 : 1049 1053.
49. Van Hare GF, Franz MR, Roge C, Scheinman MM. Persistent functional atrioventricular block in two patients with prolonged QT intervals: elucidation of the mechanism of block. Pacing Clin Electrophysiol 1990 13 : 608 618.
50. Cimaz R, Meroni PL, Brucato A et al. Concomitant disappearance of electrocardiographic abnormalities and of acquired maternal auto antibodies during the first year of life in infants who had QT interval prolongation and anti-SSA/Ro positivity without congenital heart block at birth. Arthritis Rheum 2003 48 : 266 268.
51. Costedoat-Chalumeau N, Amoura Z, Lupoglazoff JM et al. Outcome of pregnant patients with anti-SSA/Ro antibodies: study of 165 pregnancies, with special focus on electrocardiographic variations in the children and comparison with a control group. Arthritis Rheum 2004 50 : 3187 3194.
52. Brucato A, Frassi M, Franceschini F et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001 44 : 1832 1835.
53. Villain E, Coastedoat-Chalumeau N, Marijon E, Boudjemline Y, Piette JC, Bonnet D. Presentation and prognosis of complete Atrioventricular Block in childhood According to maternal Antibody Status. J Am Coll Cardiol 2006 48 : 1682 1687.
54. Cuneo BF, Strasburger JF, Niksch A, Ovadia M, Wakai RT. An expanded phenotype of maternal SSA/SSB antibody-associated fetal cardiac disease. J Matern Fetal Neonatal Med, 2009 22 : 233 238.
55. Eghtesady P. Hypoplastic left heart syndrome: rheumatic heart disease of the fetus? Med hypotheses 2006 66 : 554 565.